Choroidal neovascularisation is a serious eye condition where abnormal blood vessels grow beneath the retina, threatening the sharp vision you use for reading, recognising faces, and driving. Understanding this condition and acting quickly when symptoms appear can make the difference between preserving your sight and experiencing permanent vision loss.

Understanding the Outlook: What to Expect with Choroidal Neovascularisation

When someone receives a diagnosis of choroidal neovascularisation, one of the first questions that comes to mind is naturally about what lies ahead. The outlook for this condition depends heavily on how quickly treatment begins and how the abnormal blood vessels respond to therapy. This is not a journey anyone wants to take, but understanding what may happen can help you prepare and make informed decisions alongside your medical team.

The prognosis for choroidal neovascularisation varies considerably from person to person. Some individuals respond well to treatment and maintain functional vision for many years, while others face more challenging outcomes. Research examining the natural history of this condition in people with extreme nearsightedness found that without treatment, approximately 90% of eyes developed macular atrophy over an average follow-up period of nearly 12 years. Even more sobering, about 96% of untreated eyes had vision of 20/200 or worse at the 10-year mark—a level considered legally blind in many places.^[11]

However, these statistics reflect outcomes without modern treatment. The introduction of anti-VEGF therapy—medications that block a protein called vascular endothelial growth factor—has fundamentally changed what patients can expect. Anti-VEGF drugs work by targeting the signal that causes abnormal blood vessels to grow and leak. When delivered promptly, they can halt or even reverse some of the damage. Many patients experience stabilisation of their vision, and some see improvement in how clearly they can see.

Despite these advances, it is important to understand that choroidal neovascularisation is a chronic condition requiring ongoing monitoring and often repeated treatments. The abnormal blood vessels have a tendency to become active again, which is why regular follow-up appointments are essential. Some patients need injections every few months for years, while others may go longer between treatments. The burden of repeated eye injections can feel overwhelming, both physically and emotionally.

One of the challenges with predicting individual outcomes is that not everyone responds to treatment in the same way. While most patients benefit from anti-VEGF therapy, a subset of people do not respond well initially, and another group may develop resistance over time. When someone has received multiple injections and the blood vessels continue to leak or grow despite treatment, doctors describe this as treatment resistance or reduced biological response. This occurs in roughly one-quarter of patients who are unresponsive from the start, and about one-third of those who initially respond may become resistant after repeated doses.^[10]

The development of scar tissue beneath the retina represents another factor influencing long-term outcomes. Even with successful treatment that stops the blood vessels from leaking, some scarring may have already occurred by the time therapy begins. This scarring, sometimes called a disciform scar, can permanently affect the central vision. The extent of this scarring and the underlying health of the retina before treatment begins are significant determinants of how much vision can be preserved or restored.

How the Condition Develops Without Treatment

Understanding what happens when choroidal neovascularisation goes untreated helps illustrate why prompt intervention matters so much. The disease process begins when the body produces excessive amounts of vascular endothelial growth factor in the retina. This protein normally plays a role in maintaining healthy blood vessels, but when present in abnormally high levels, it triggers the growth of new blood vessels from the choroid—a layer underneath the retina that contains blood vessels supplying oxygen and nutrients to the outer portions of the retina.^[1]

These newly formed vessels are fundamentally different from normal, healthy blood vessels. They are fragile and poorly constructed, with walls that leak. Fluid from the blood, and sometimes even red blood cells themselves, seeps through these defective vessel walls and enters spaces where it does not belong—between the layers of the retina or beneath the retinal pigment epithelium, a thin layer of cells that supports the retina’s light-sensing cells.

When fluid accumulates beneath or within the retina, it creates what can be described as a blister. The retina, which is normally flat and smooth, becomes distorted and elevated. This distortion immediately affects vision because the light-sensing cells, called photoreceptors, can no longer function properly when displaced from their normal position. Straight lines appear wavy or bent—a symptom called metamorphopsia—and the central vision becomes blurred or obscured by a grey or dark spot.

The accumulation of fluid is not just a temporary inconvenience. Over the course of days to months, the presence of fluid and blood damages the delicate photoreceptor cells. These cells, which capture light and convert it into electrical signals that the brain interprets as vision, begin to die. Once photoreceptors are destroyed, they cannot regenerate. This is why delays in treatment can result in irreversible vision loss.

As time passes without intervention, the body attempts to heal the damaged area. Unfortunately, this healing process involves the formation of scar tissue. The abnormal blood vessels, along with surrounding tissue, become replaced by fibrous scar material—the disciform scar mentioned earlier. This scar tissue is opaque and blocks light from reaching the remaining photoreceptors. It also disrupts the normal architecture of the retina, making it impossible for that portion of the retina to function even if new treatments are later introduced.

In addition to central scar formation, the chronic leakage and inflammation can lead to progressive atrophy of the retinal tissue and the underlying choroid. Chorioretinal atrophy represents widespread tissue loss and thinning. Studies examining long-term outcomes found that this atrophy was present in the vast majority of untreated eyes and remains the most important factor determining visual outcome.^[11] Even when treatment is eventually started, the damage from prolonged untreated disease may be so extensive that vision cannot be recovered.

Possible Complications and Unexpected Developments

Choroidal neovascularisation can lead to several complications that worsen the prognosis and complicate treatment. Being aware of these potential developments helps patients understand why close monitoring is necessary and why symptoms should never be ignored.

One significant complication is bleeding within the eye. The fragile abnormal blood vessels can rupture, causing subretinal haemorrhage—bleeding beneath the retina. When blood accumulates in this space, it not only blocks vision directly but also damages the photoreceptors through toxic effects. Large haemorrhages can be particularly devastating, sometimes leading to sudden and severe vision loss. The blood must be absorbed by the body over time, and even after it clears, permanent damage may remain.

Another complication involves the accumulation of lipids, or fatty deposits, within the retina. When blood vessels leak chronically, proteins and fats from the blood can deposit in the retinal tissue. These deposits, called lipid exudation, appear as yellowish material on examination. They interfere with retinal function and can cause additional vision distortion. Over time, these deposits contribute to scarring and permanent tissue damage.

The formation of a pigment epithelial detachment represents another complication. This occurs when fluid accumulates beneath the retinal pigment epithelium, causing it to lift away from the underlying tissue. The retinal pigment epithelium plays a critical role in nourishing photoreceptors and removing waste products. When it becomes detached, photoreceptors lose essential support, accelerating their deterioration. Pigment epithelial detachments can be particularly resistant to treatment and may require adjusted therapy approaches.

Some patients develop what doctors call treatment resistance or tachyphylaxis. This means that after initially responding well to anti-VEGF injections, the blood vessels stop responding to the medication. The abnormal vessels continue to leak despite ongoing treatment. This phenomenon may occur because the body finds alternative pathways to stimulate blood vessel growth, such as increasing production of other growth factors beyond VEGF. When this happens, doctors may need to change medications, increase the dose, shorten the interval between injections, or add other therapies.^[10]

Another concern is that repeated treatments, while necessary, carry their own risks. Frequent eye injections can lead to increased eye pressure, inflammation inside the eye, infection, bleeding, retinal tears, or even retinal detachment—a serious condition where the retina pulls away from its supporting tissue. Although these complications from treatment are relatively uncommon, they represent real risks that must be weighed against the benefits of therapy.

In some cases, the underlying condition causing the choroidal neovascularisation may progress. For instance, if the neovascularisation is secondary to age-related macular degeneration, the dry form of that disease may continue advancing in other areas of the retina, leading to additional vision loss not directly related to the blood vessel growth. Similarly, in people with extreme nearsightedness, the eye may continue to elongate and stretch, potentially triggering new areas of blood vessel growth or causing additional retinal complications.

Impact on Daily Life and Living with Vision Changes

Choroidal neovascularisation affects far more than just the ability to see clearly—it touches nearly every aspect of daily living. Understanding these impacts helps patients and their families prepare for challenges and find ways to adapt.

The most immediate impact is on tasks requiring central vision. Reading becomes difficult or impossible without assistance. Words may appear wavy, distorted, or obscured by a dark spot. Many people find they can no longer enjoy books, newspapers, or messages on their phones in the same way. This loss affects not only information access but also the pleasure and relaxation that reading provides.

Recognising faces becomes problematic. When the central vision is impaired, seeing facial features clearly enough to identify people is challenging. Patients often report feeling embarrassed or isolated when they cannot recognise friends or family members from a distance, or sometimes even up close. Social interactions become anxiety-provoking, as there is fear of appearing rude or disconnected when failing to acknowledge someone.

Driving is often no longer safe or legally permitted. The central vision is essential for seeing traffic signals, reading road signs, and detecting pedestrians and vehicles. Many jurisdictions require specific visual acuity standards for maintaining a driving licence. Losing the ability to drive represents a profound loss of independence for many people, affecting employment, social activities, and the ability to run errands or attend medical appointments without relying on others.

Work can become extremely challenging, particularly for those in occupations requiring detailed visual tasks. Computer work, reading documents, assembly work, inspection tasks, and many other jobs become difficult or impossible. Some people must reduce their hours, change roles, or stop working altogether. This loss of employment affects not only income but also sense of purpose, identity, and social connections that work provides.

Everyday household tasks present new obstacles. Cooking becomes more difficult when you cannot clearly see what you are cutting or read labels and recipes. Managing medications is risky when you cannot distinguish between pill bottles or read dosage instructions. Handling finances, whether paying bills or managing bank accounts, requires clear vision. Even simple tasks like matching clothes, grooming, or navigating your own home can become challenging if lighting is poor or if the layout changes.

The emotional and psychological impact should not be underestimated. Vision loss, particularly when it affects independence, often leads to feelings of grief, frustration, anxiety, and depression. Fear about the future and worry about becoming a burden on family members are common. Many people experience a loss of confidence and may withdraw from activities they once enjoyed. The ongoing need for repeated eye injections can cause anticipatory anxiety and stress.

Social and recreational activities may be curtailed. Hobbies such as sewing, crafting, painting, bird watching, or playing cards may become difficult. Going to the cinema or theatre, watching television, or enjoying sporting events is less enjoyable when you cannot see clearly. Some people stop attending social gatherings because navigating unfamiliar environments is stressful or because they feel self-conscious about their vision limitations.

Physical safety is another concern. Depth perception can be affected by central vision loss, increasing the risk of trips and falls. Noticing obstacles, steps, or uneven surfaces becomes harder. Some people experience increased caution or fearfulness when moving around, even in familiar environments, which can further limit activity levels and independence.

There are, however, strategies and resources that can help. Many communities offer low vision rehabilitation services, where specialists teach techniques for maximising remaining vision. These might include learning to use eccentric viewing—looking slightly to the side of an object to use healthier parts of the retina. Magnifying devices, whether handheld, stand-mounted, or electronic, can make reading possible again. Large-print materials, audio books, and screen-reading software provide alternative ways to access information.

Improving lighting at home makes a significant difference. Brighter lights, reduced glare, and task lighting for specific activities help many people see better. Increasing contrast—using dark pens on white paper, marking controls and dials with tactile markers, using contrasting colours for different items—makes objects easier to distinguish. Reducing clutter and establishing permanent places for frequently used items minimises frustration and safety risks.

Support groups, whether in person or online, provide valuable emotional support and practical advice from others facing similar challenges. Sharing experiences, learning how others have adapted, and simply knowing you are not alone can be profoundly helpful. Mental health support, whether through counselling or therapy, can help address feelings of grief, anxiety, or depression that often accompany vision loss.

Supporting Family Members: What Loved Ones Need to Know

When someone in your family has choroidal neovascularisation, understanding how to provide support can make an enormous difference in their experience and outcomes. Family members play a crucial role not only in emotional support but also in practical assistance and treatment decisions.

One important area where family can help is understanding and navigating clinical trials. Clinical trials are research studies that test new treatments or approaches to managing diseases. For choroidal neovascularisation, trials might investigate new medications, different treatment schedules, combination therapies, or novel drug delivery methods. Participation in a clinical trial may provide access to cutting-edge treatments before they become widely available, though it is important to understand that experimental therapies may not work and could potentially have unknown side effects.

Families can assist by helping their loved one research available trials. Many trials have specific eligibility criteria regarding age, disease stage, previous treatments, and other health conditions. Finding trials that match can be time-consuming and confusing. Family members can help search trial registries, contact study coordinators to ask questions, and help evaluate whether participation might be beneficial.

Understanding what trial participation involves is essential. Clinical trials often require more frequent visits, additional testing, and detailed record-keeping compared to standard care. There may be requirements about continuing or discontinuing current treatments. Travel to the study site may be necessary, sometimes repeatedly over months or years. Families should discuss these practical considerations together to determine whether participation is feasible.

Another way families can support trial participation is by accompanying their loved one to appointments. Having a second person present helps ensure important information is not missed, questions are remembered and asked, and complex explanations are better understood. Family members can take notes, ask for clarification, and help remember details later when making decisions.

Preparing for trial participation also means understanding informed consent. This process involves learning about the study’s purpose, procedures, potential risks and benefits, alternatives, and rights as a participant. The information can be overwhelming. Family members can help by reading consent documents together, writing down questions, and ensuring the patient understands what they are agreeing to before signing.

Transportation is a practical concern that family can address. When someone’s vision is impaired, driving may not be possible. Family members can provide rides to appointments, including the regular treatment visits, follow-up examinations, and any emergency visits that may be needed. This support removes a significant barrier to receiving care and reduces stress.

Beyond clinical trials, families can assist with general treatment management. Keeping track of appointment schedules, helping organise medications, ensuring eye drops are administered properly if prescribed, and watching for changes in symptoms are all valuable contributions. Family members often notice changes that the patient may not recognise or may hesitate to report.

Emotional support remains perhaps the most important role family can play. Vision loss is frightening and can lead to feelings of helplessness, frustration, and depression. Simply being present, listening without judgment, acknowledging the difficulty of the situation, and offering reassurance helps immeasurably. Avoiding dismissive statements like “it could be worse” and instead validating the person’s experience builds trust and connection.

Families should also educate themselves about the condition. Understanding what choroidal neovascularisation is, why treatment is necessary, what the prognosis involves, and what complications might occur helps family members provide informed support and ask relevant questions during medical appointments. It also helps them recognise when urgent care is needed.

Encouraging independence while offering appropriate help requires balance. Overprotecting or doing too much can undermine the person’s confidence and capability. Conversely, not offering enough help can leave them struggling unnecessarily. Open communication about what kind of help is wanted and needed makes this balance easier to achieve.

Practical assistance with daily tasks can be invaluable. This might include helping with reading mail, managing finances, preparing meals, shopping, organising the home for easier navigation, or installing better lighting. The key is to assist in ways that empower rather than create dependence.

Finally, families should also take care of themselves. Supporting someone with vision loss can be emotionally draining and time-consuming. Caregivers need their own support systems, time for self-care, and sometimes professional help to manage stress. Support groups for family members of people with vision loss exist and can provide both practical advice and emotional support.